Found: 48
Select item for more details and to access through your institution.
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping.
- Published in:
- Breast Journal, 2012, v. 18, n. 4, p. 303, doi. 10.1111/j.1524-4741.2012.01264.x
- By:
- Publication type:
- Article
Tumors, History.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
Bathsheba's Breast (Book).
- Published in:
- 2002
- By:
- Publication type:
- Book Review
Improving Tolerance of AIs: Predicting Risk and Uncovering Mechanisms of Musculoskeletal Toxicity.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 12, p. 1416
- By:
- Publication type:
- Article
Myeloid Growth Factor Support for Dose-Dense Adjuvant Chemotherapy for Breast Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, p. 13
- By:
- Publication type:
- Article
Response.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 9, p. 642, doi. 10.1093/jnci/djn100
- By:
- Publication type:
- Article
Do patients participating in clinical trials want to know study results?
- Published in:
- 2003
- By:
- Publication type:
- letter
Side Effects of Chemotherapy and Combined Chemohormonal Therapy in Women With Early-Stage Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 30, p. 135
- By:
- Publication type:
- Article
Adjuvant Capecitabine in Triple-Negative Breast Cancer: New Strategies for Tailoring Treatment Recommendations.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
- Published in:
- 2017
- By:
- Publication type:
- editorial
ASO Visual Abstract: Defining the Biology of Estrogen Receptor-Low Positive Breast Cancer.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 4, p. 2244, doi. 10.1245/s10434-023-14835-z
- By:
- Publication type:
- Article
ASO Visual Abstract: Expanding Staging Criteria in T1–2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8016, doi. 10.1245/s10434-022-12225-5
- By:
- Publication type:
- Article
ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7674, doi. 10.1245/s10434-022-12032-y
- By:
- Publication type:
- Article
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 204, n. 1, p. 123, doi. 10.1007/s10549-023-07167-9
- By:
- Publication type:
- Article
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 123, doi. 10.1007/s10549-023-07167-9
- By:
- Publication type:
- Article
A dynamic portrait of adverse events for breast cancer patients: results from a phase II clinical trial of eribulin in advanced HER2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 1, p. 135, doi. 10.1007/s10549-020-05928-4
- By:
- Publication type:
- Article
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 347, doi. 10.1007/s10549-020-05622-5
- By:
- Publication type:
- Article
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 176, n. 2, p. 303, doi. 10.1007/s10549-019-05238-4
- By:
- Publication type:
- Article
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 8, p. 981, doi. 10.1093/jnci/djad065
- By:
- Publication type:
- Article
Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Trastuzumab: qui bono?
- Published in:
- 2013
- By:
- Publication type:
- editorial
Trastuzumab: Qui Bono?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 23, p. 1772, doi. 10.1093/jnci/djt336
- By:
- Publication type:
- Article
Who Seeks Alternative Treatment?
- Published in:
- Harvard Mental Health Letter, 2000, v. 16, n. 7, p. 7
- By:
- Publication type:
- Article
A look at current and potential treatment approaches for hormone receptor‐positive, HER2‐negative early breast cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, p. 2209, doi. 10.1002/cncr.34161
- By:
- Publication type:
- Article
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
New Combinations with Herceptin[sup ®] in Metastatic Breast Cancer.
- Published in:
- Oncology, 2001, v. 61, p. 50, doi. 10.1159/000055402
- By:
- Publication type:
- Article
Patient advocates' role in clinical trials.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4801, doi. 10.1002/cncr.27485
- By:
- Publication type:
- Article
Radiation therapy for ductal carcinoma in situ: a decision analysis.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Radiation therapy for ductal carcinoma in situ.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 603, doi. 10.1002/cncr.26293
- By:
- Publication type:
- Article
Trastuzumab Plus Vinorelbine or Taxane Chemotherapy for HER2-overexpressing Metastatic Breast Cancer: The Trastuzumab and Vinorelbine or Taxane Study.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 5, p. 965, doi. 10.1002/cncr.22885
- By:
- Publication type:
- Article
Multidisciplinary considerations in the treatment of triple‐negative breast cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2020, v. 70, n. 6, p. 432, doi. 10.3322/caac.21643
- By:
- Publication type:
- Article
Update in Hematology and Oncology: Evidence Published in 2015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
How Old is Too Old? Breast Cancer Treatment in Octogenarians.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 6, p. 1458, doi. 10.1245/s10434-018-6457-y
- By:
- Publication type:
- Article
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance).
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 3, p. 1, doi. 10.1093/jncics/pkab025
- By:
- Publication type:
- Article
HER2 overexpressing metastatic breast cancer.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Neoadjuvant Pertuzumab: the Exception That Proves the Rule?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 3, p. 197
- By:
- Publication type:
- Article
The dilemma of selecting a first line CDK4/6 inhibitor for hormone receptor-positive/HER2-negative metastatic breast cancer.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00520-7
- By:
- Publication type:
- Article
Treatment discontinuation, patient-reported toxicities and quality-of-life by age following trastuzumab emtansine or paclitaxel/trastuzumab (ATEMPT).
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00495-x
- By:
- Publication type:
- Article
Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 1, p. 24, doi. 10.1016/j.clbc.2014.07.010
- By:
- Publication type:
- Article
Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor--2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 4, p. 254, doi. 10.1016/j.clbc.2013.02.010
- By:
- Publication type:
- Article
The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early‐stage breast cancer: A decision analysis.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 12, p. 2576
- By:
- Publication type:
- Article
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 12, p. 2972
- By:
- Publication type:
- Article